论文部分内容阅读
目的:探讨奥美拉唑联合康复新液治疗消化道溃疡的效果。方法:将我院收治的92例消化道溃疡患者随机均分为治疗组与对照组,各46例。两组患者均给予呋喃唑酮90mg、阿莫西林1000mg、奥美拉唑20mg,2次/d口服,7d为l个疗程。第3~5周,治疗组给予康复新液9.5m L,3次/d,奥美拉唑20mg,1次/d;对照组患者仅给予奥美拉唑20mg,1次/d。治疗阶段均不服用其他抗溃疡药物。结果:治疗组总有效率显著高于对照组,复发率显著低于对照组,差异有统计学意义(P均<0.05);两组不良反应对比无显著差异(P>0.05)。结论:采用奥美拉唑联合康复新液治疗消化道溃疡能够取得显著的效果,并且复发率低,值得临床推广。
Objective: To investigate the effect of omeprazole combined with rehabilitation new liquid on the treatment of peptic ulcer. Methods: 92 cases of peptic ulcer patients admitted to our hospital were randomly divided into treatment group and control group, with 46 cases in each. Two groups of patients were given furazolidone 90mg, amoxicillin 1000mg, omeprazole 20mg, 2 times / d orally, 7d for a course of treatment. The third to fifth weeks, the treatment group was given Kangfuxin solution 9.5m L, 3 times / d, omeprazole 20mg, 1 / d; control group received only omeprazole 20mg, 1 / d. During the treatment are not taking other anti-ulcer drugs. Results: The total effective rate in the treatment group was significantly higher than that in the control group, the recurrence rate was significantly lower than that in the control group (P <0.05). There was no significant difference in adverse reaction between the two groups (P> 0.05). Conclusion: The combination of omeprazole and Kangfuxin solution in the treatment of peptic ulcer can achieve remarkable results, and the recurrence rate is low, worthy of clinical promotion.